Lundbeck reference case

With production facilities in Denmark, France and Italy, research centres in Denmark and the US and a worldwide sales and distribution reach, Lundbeck has been reimbursing between 2,500 and 3,000 employee expense claims a month during COVID, and expects this to increase to 4,000 post-COVID.

Bettering the lives of people living with brain diseases requires a multifaceted approach. Beyond developing transformative medical therapies, Lundbeck strives to make a difference for patients and supports its employees in this endeavour by smoothing their working practices and administration.